Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Current Opinions" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Current Opinions for you to read. Along with our medical data and news we also list Current Opinions Clinical Trials, which are updated daily. BioPortfolio also has a large database of Current Opinions Companies for you to search.
FitLife Brands, Inc. (“FitLife”) (OTC Pink: FTLF), an international provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition Products™ ("NDS") (www.ndsnutrition.com), PMD® (www.pmdsports.com), SirenLabs® (
Robots that mimic the collective migration of biological cells are described in a paper published in Nature. This alternative approach to developing large-scale robotic systems may be more scalable and robust than some current bio-inspired systems. https
Robots that mimic the collective migration of biological cells are described in a paper published in Nature. This alternative approach to developing large-scale robotic systems may be more scalable and robust than some current bio-inspired systems. https://go.nature.com/2YdeiAL pic.twitter.com/uZkvNn4S0l
New data on the state of value-based care in oncology has found that while community oncologists are optimistic about the beneficial potential of value-based care, they see a conflict between the need to decrease episode costs and the rising prices of the most innovative novel therapies. In an effort to dig deeper into current attitudes ... Read More
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
Eli Lilly and Company Eli Lilly and Company: Eli Lilly and Company calls company stockholders meeting 22-March-2019 / 14:50 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. ELI LILLY AND COMPANY CALLS STOCKH
The summit will feature expert faculty from Memorial Sloan Kettering Cancer Center OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on ovarian cancer and soft tiss...
Current approaches to identifying people who are at high risk for overdosing on opioids target many who are not truly at high risk.
The Asbestos Disease Awareness Organization (ADAO), an independent nonprofit dedicated to preventing asbestos exposure; today announced the honorees for its 15th Annual Intern
Gov. Cooper to cut ribbon on facility that will strengthen bluebird bio's capabilities to manufacture products for clinical development and commercial supply bluebird bio, Inc. (Nasdaq: BLUE) today announced the official opening of its first wholly owned manufacturing facility in Durham, N.C., that will produce lentiviral vector for the company’s inv...
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer Ovarian cancer is the fifth leading cause of cancer death among women Novocure (NASDAQ: NVCR) announced today that it has initiated INNOVATE-3, a phase 3 pivotal trial testing the efficacy of Tumor ...
Professor Tibor Hlavatý, from United European Gastroenterology, which is a European umbrella organisation for gastroenterologists, gave a presentation on the current position of biosimilars in the field of gastroenterology at the fourth European Commission Stakeholder Conference on Biosimilar Medicines, which was held on 14 September 2018 in Brussels, Belgium .
News report People with a certain type of lymphoma will now have access to a targeted cancer drug on the NHS in England. Brentuximab vedotin (Adcetris) was approved by the Nation
(McGill University) Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research. A team of scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University may have f...
Attained multiple milestones in DECIDE1/2 clinical program in advanced ovarian cancer Achieved initial positive data from phase 2 clinical trial in DLBCL with Merck Initiated a phase 2 basket trial across five indications under a collaboration with Merck Listed on Nasdaq and changed Corpora...
Damian Laber, MD, provides a brief history of the trials that led to current frontline and second-line standards for patients with metastatic pancreatic cancer and shares his hope for the future of the treatment paradigm.
Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (Nasdaq:TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), is pleased to announce the closing of its previously announced public offering (the “Offering”) pursuant ...
Tekla Healthcare Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2019. The renewal will allow the Fund to purchase in the ...
Regulatory News: Advicenne (Paris:ADVIC) (Euronext: ADVIC - FR0013296746), a pharmaceutical company specializing in the development of adult and pediatric therapeutic products for the treatment of orphan renal and neurological diseases, announces its financial results for the full year ended December 31, 2018. The late-stage French biopharmac...
Yesterday, on March 20, 2019, Oncology Venture A/S published its annual report for 2018 with information on the company's financial situation. The current rules of First North state that a listed c...
The topic of this month’s newsletter from Drug Discovery Today is “Cancer”.
Rite Aid Corporation (NYSE: RAD) announced that its stockholders approved a reverse stock split of the company’s common stock at today’s Special Meeting of Stockholders. According to preliminary tabulations, with approximately 987 million eligible votes cast, stockholders voted 78% in favor of the reverse split. Rite Aid’s Board of Directors...
The three-day meeting will provide educational opportunities in all areas of oncology. OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, announced Edward Kim, MD, FACP, a clinical oncology expert, as the program chai...
-- Presenting early data in collaboration with TriStar Technology Group -- Cofactor Genomics today announced that Natalie LaFranzo, the company’s Director of Scientific Projects and Market Development, will present at the 2019 Annual Meeting of the American Association for Cancer Research (AACR) being held at the Georgia World Congress Center in Atla...